Literature DB >> 21455209

Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins?

Kazim H Narsinh1, Jordan Plews, Joseph C Wu.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21455209      PMCID： PMC3070108          DOI： 10.1038/mt.2011.41

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  28 in total

Review 1.  Differences between human embryonic stem cell lines.

Authors:  C Allegrucci; L E Young
Journal:  Hum Reprod Update       Date:  2006-08-26       Impact factor: 15.610

2.  Direct multiplexed measurement of gene expression with color-coded probe pairs.

Authors:  Gary K Geiss; Roger E Bumgarner; Brian Birditt; Timothy Dahl; Naeem Dowidar; Dwayne L Dunaway; H Perry Fell; Sean Ferree; Renee D George; Tammy Grogan; Jeffrey J James; Malini Maysuria; Jeffrey D Mitton; Paola Oliveri; Jennifer L Osborn; Tao Peng; Amber L Ratcliffe; Philippa J Webster; Eric H Davidson; Leroy Hood; Krassen Dimitrov
Journal:  Nat Biotechnol       Date:  2008-02-17       Impact factor: 54.908

3.  MicroRNA profiling of human-induced pluripotent stem cells.

Authors:  Kitchener D Wilson; Shivkumar Venkatasubrahmanyam; Fangjun Jia; Ning Sun; Atul J Butte; Joseph C Wu
Journal:  Stem Cells Dev       Date:  2009-06       Impact factor: 3.272

4.  Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

Authors:  Frank Soldner; Dirk Hockemeyer; Caroline Beard; Qing Gao; George W Bell; Elizabeth G Cook; Gunnar Hargus; Alexandra Blak; Oliver Cooper; Maisam Mitalipova; Ole Isacson; Rudolf Jaenisch
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

5.  iPS cells can support full-term development of tetraploid blastocyst-complemented embryos.

Authors:  Lan Kang; Jianle Wang; Yu Zhang; Zhaohui Kou; Shaorong Gao
Journal:  Cell Stem Cell       Date:  2009-07-23       Impact factor: 24.633

6.  A functionally characterized test set of human induced pluripotent stem cells.

Authors:  Gabriella L Boulting; Evangelos Kiskinis; Gist F Croft; Mackenzie W Amoroso; Derek H Oakley; Brian J Wainger; Damian J Williams; David J Kahler; Mariko Yamaki; Lance Davidow; Christopher T Rodolfa; John T Dimos; Shravani Mikkilineni; Amy B MacDermott; Clifford J Woolf; Christopher E Henderson; Hynek Wichterle; Kevin Eggan
Journal:  Nat Biotechnol       Date:  2011-02-03       Impact factor: 54.908

7.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.

Authors:  Mark H Chin; Mike J Mason; Wei Xie; Stefano Volinia; Mike Singer; Cory Peterson; Gayane Ambartsumyan; Otaren Aimiuwu; Laura Richter; Jin Zhang; Ivan Khvorostov; Vanessa Ott; Michael Grunstein; Neta Lavon; Nissim Benvenisty; Carlo M Croce; Amander T Clark; Tim Baxter; April D Pyle; Mike A Teitell; Matteo Pelegrini; Kathrin Plath; William E Lowry
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

8.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

9.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

10.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582
View more
  43 in total

Review 1.  Tissue Engineering and Regenerative Medicine 2015: A Year in Review.

Authors:  Holly Wobma; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part B Rev       Date:  2016-02-23       Impact factor: 6.389

2.  Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Won Hee Lee; Wen-Yi Chen; Ning-Yi Shao; Dan Xiao; Xulei Qin; Natalie Baker; Hye Ryeong Bae; Tzu-Tang Wei; Yongjun Wang; Praveen Shukla; Haodi Wu; Kazuki Kodo; Sang-Ging Ong; Joseph C Wu
Journal:  Stem Cells       Date:  2017-07-31       Impact factor: 6.277

Review 3.  Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models.

Authors:  Alexa Wnorowski; Huaxiao Yang; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2018-06-06       Impact factor: 15.470

4.  Mass spectrometry-based proteomic analysis of the matrix microenvironment in pluripotent stem cell culture.

Authors:  Chris Hughes; Lida Radan; Wing Y Chang; William L Stanford; Dean H Betts; Lynne-Marie Postovit; Gilles A Lajoie
Journal:  Mol Cell Proteomics       Date:  2012-09-27       Impact factor: 5.911

Review 5.  Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery.

Authors:  Erkan Kiris; Krishna P Kota; James C Burnett; Veronica Soloveva; Christopher D Kane; Sina Bavari
Journal:  Expert Rev Mol Diagn       Date:  2014-01-23       Impact factor: 5.225

6.  Effect of Glucose on 3D Cardiac Microtissues Derived from Human Induced Pluripotent Stem Cells.

Authors:  Michael Balistreri; Justin A Davis; Katherine F Campbell; André Monteiro Da Rocha; Marjorie C Treadwell; Todd J Herron
Journal:  Pediatr Cardiol       Date:  2017-07-27       Impact factor: 1.655

Review 7.  Stem cell manipulation, gene therapy and the risk of cancer stem cell emergence.

Authors:  Flora Clément; Elodie Grockowiak; Florence Zylbersztejn; Gaëlle Fossard; Stéphanie Gobert; Véronique Maguer-Satta
Journal:  Stem Cell Investig       Date:  2017-07-25

Review 8.  Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives.

Authors:  Maggie Chow; Kenneth R Boheler; Ronald A Li
Journal:  Stem Cell Res Ther       Date:  2013-08-14       Impact factor: 6.832

9.  Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line.

Authors:  Lauren R Moore; Laura Keller; David D Bushart; Rodrigo G Delatorre; Duojia Li; Hayley S McLoughlin; Maria do Carmo Costa; Vikram G Shakkottai; Gary D Smith; Henry L Paulson
Journal:  Stem Cell Res       Date:  2019-07-16       Impact factor: 2.020

Review 10.  Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.

Authors:  Alison E Mungenast; Sandra Siegert; Li-Huei Tsai
Journal:  Mol Cell Neurosci       Date:  2015-12-04       Impact factor: 4.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.